IONIS-JBI1-2.5Rx

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameIONIS-JBI1-2.5Rx
Drug Alias NameIONIS-JBI1-2.5Rx
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionImmunomodulatorsProtein biosynthesis inhibitors
TargetsNot applicable
Therapy Area/IndicationsAutoimmune DiseasesInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesJohnson & Johnson Innovative MedicineIonis Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A